Analysts have recently evaluated Evolent Health (NYSE: EVH) and provided ratings and price targets based on their analysis of the company’s performance and market conditions. Here is a breakdown of the latest analyst actions and key insights:
—
Analyst Ratings:
– 1 Bullish, 3 Somewhat Bullish, 0 Indifferent, 0 Somewhat Bearish, 0 Bearish in total.
– In the last 30 days: 1 Bullish, 1 Somewhat Bullish, 0 Indifferent, 0 Somewhat Bearish, 0 Bearish.
– 1 Month Ago: No ratings provided.
– 2 Months Ago: No ratings provided.
– 3 Months Ago: 2 Somewhat Bullish, 0 Indifferent, 0 Somewhat Bearish, 0 Bearish.
Price Targets:
– The 12-month average price target for Evolent Health is $40.5, with a high estimate of $45.00 and a low estimate of $37.00.
Recent Analyst Actions:
– Constantine Davides raised market outperform ratings from $37.00 to $38.00.
– Richard Close lowered buy ratings from $47.00 to $45.00.
Key Insights:
– Analysts adjust their recommendations based on market conditions and company performance.
– Recent changes in ratings and price targets reflect analysts’ responses to developments concerning Evolent Health.
– The consensus among analysts suggests a moderate buy rating for Evolent Health with an average price target of $40.71.
– The stock has a Smart Score of 9 and an average rating score of 2.89 out of 5 stars.
– Evolent Health recently reported an EPS of $0.14, with Farallon Capital Management, L.L.C. being one of the major shareholders.
For more detailed information on analyst estimates and forecasts for Evolent Health, consult financial platforms such as TipRanks, Markets Insider, Yahoo Finance, and Nasdaq.
—
Date: February 23, 2024
Envision Healthcare Corporation (EVH) Stock Surges 13.13% on February 23, 2024: Positive Price Momentum Ahead
On February 23, 2024, Envision Healthcare Corporation (EVH) saw a significant increase in its stock performance. The stock opened at $32.75, which was $2.98 higher than its previous close. Throughout the day, the price of EVH shares continued to rise, ultimately increasing by $3.91, or 13.13%, since the market last closed.
One notable aspect of EVH’s performance on this day is its price momentum. The stock is trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that EVH has been experiencing positive price movement and may continue to do so in the near future.
EVH Stock Shows Promising Performance with Strong Financial Results on February 23, 2024
On February 23, 2024, EVH stock showed promising performances as the company reported strong financial results. According to data from CNN Money, EVH’s total revenue for the past year stood at $1.35 billion, marking a significant increase of 48.91% compared to the previous year. In the third quarter alone, the company generated $511.01 million in revenue, representing an 8.93% increase from the previous quarter.
EVH’s net income also showed positive growth trends. The company reported a net loss of $18.66 million for the past year, a 39.4% improvement from the previous year. In the third quarter, EVH’s net loss narrowed to $25.32 million, reflecting a 26.22% improvement from the previous quarter.
EVH’s earnings per share (EPS) also demonstrated strong growth. The company’s EPS for the past year was -$0.20, a 44.34% improvement from the previous year. In the third quarter, EVH’s EPS improved to -$0.30, marking a 20.53% increase from the previous quarter.
Overall, EVH’s financial performance on February 23, 2024, showcased a positive trajectory with significant improvements in total revenue, net income, and earnings per share. Investors may view these results as a sign of the company’s strong growth potential and may consider EVH stock as a promising investment opportunity in the future.
